Saturday, April 27, 2019

Lung cancer risks in never smokers under recognized

Air pollution is an overlooked  risk factor for lung cancer 
 – Image Wikipedia Creative Commons copyright.
CANCER DIGEST – April 27, 2019 – About 30,000 Americans who have never smoked die of lung cancer each year, according to the American Cancer Society

Now a group of British respiratory therapists and public health experts are calling for greater recognition of lung cancer in never-smokers.

Saturday, April 20, 2019

More evidence that physical activity does a body good

CANCER DIGEST – April 20, 2019 – Another study about physical activity and health has shown that increased physical activity of any type reduces overall risk of dying regardless of age, sex, or starting fitness level.

The Swedish study was presented in Lisbon, Portugal at EuroPrevent 2019, a conference of the European Society of Cardiology.

Friday, April 12, 2019

Proton therapy shown safe and effective for childhood neuroblastomas

Image courtesy CHOP News
CANCER DIGEST – April 12, 2019 – Proton therapy is both effective in reducing a common childhood tumor while posing little risk to nearby organs, a new study shows.

Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine analyzed the largest group of pediatric patients to date with high-risk neuroblastoma treated with proton therapy. 


Neuroblastoma is a cancer of immature nerve cells found most commonly in the adrenal glands. The study is published online in the International Journal of Radiation Oncology.

Saturday, April 6, 2019

Anti-cancer vaccine linked to dramatic reduction of other cervical disease

Photo courtesy BMJ
CANCER DIGEST – April 6, 2019 – Researchers in Scotland have found that women born between 1995 and 1996 who were vaccinated against HPV had a 89 percent reduction in the highest grade of cervical intraepithelial neoplasia (CIN3), the type of lesions indicating the highest risk of invasive cervical cancer. 


CIN is categorized by risk for developing cancer with CIN1 at lowest risk, up to CIN3 at highest risk.